Moderna, Inc. (MRNA)
Moderna Market Cap : 19.16B for April 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 181.80B |
| Gilead Sciences, Inc. | 174.48B |
| Johnson & Johnson | 575.08B |
| Eli Lilly & Co. | 820.48B |
| Arbutus Biopharma Corp. | 870.86M |
Market Cap Related Metrics
| PS Ratio | 9.670 |
| Price to Book Value | 2.216 |
| Price | 48.77 |
| Earnings Yield | -15.03% |